Aliud Pharma GmbH
Aliud Pharma GmbH, a prominent player in the pharmaceutical industry, is headquartered in Germany and operates extensively across Europe. Founded in 2004, the company has established itself as a trusted provider of high-quality generic medicines, focusing on therapeutic areas such as oncology, cardiology, and infectious diseases. With a commitment to innovation and quality, Aliud Pharma offers a diverse portfolio of products that are distinguished by their efficacy and safety. The company’s dedication to rigorous research and development has led to significant milestones, including the successful launch of numerous generic formulations that meet stringent regulatory standards. Recognised for its market position, Aliud Pharma continues to expand its reach, contributing to improved healthcare outcomes while maintaining a strong emphasis on sustainability and patient-centric solutions.
DitchCarbon Score
How does Aliud Pharma GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aliud Pharma GmbH's score of 24 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aliud Pharma GmbH's reported carbon emissions
Aliud Pharma GmbH, headquartered in Germany, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate action, often setting ambitious targets to reduce their carbon footprint. However, without specific information from Aliud Pharma, it is unclear what initiatives or commitments they may have in place regarding carbon emissions and climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Aliud Pharma GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
